Science Corp
@science.xyz
Building a brighter tomorrow enabled by neural engineering
Science Founder and CEO, Max Hodak, has been named to 2026 @TIME 100 Health.
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
February 11, 2026 at 6:20 PM
Science Founder and CEO, Max Hodak, has been named to 2026 @TIME 100 Health.
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
TIME writes: “It’s no small thing to bring eyesight to the blind—or nearly blind. But that’s what Max Hodak, founder and CEO of Science Corporation in California, has helped achieve.”
In a new interview, Frank Holz, MD, lead author and scientific coordinator of the PRIMA clinical trial now published in @nejm.org, shares his opinion on the new reality of restoring vision to clinical trial patients who had been functionally blind.
February 9, 2026 at 4:02 PM
In a new interview, Frank Holz, MD, lead author and scientific coordinator of the PRIMA clinical trial now published in @nejm.org, shares his opinion on the new reality of restoring vision to clinical trial patients who had been functionally blind.
Science founder and CEO @maxhodak.bsky.social sat down with the Berggruen Institute’s @futurologypod.bsky.social to discuss our work to improve the human condition.
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
February 4, 2026 at 4:49 PM
Science founder and CEO @maxhodak.bsky.social sat down with the Berggruen Institute’s @futurologypod.bsky.social to discuss our work to improve the human condition.
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Watch the full conversation here: youtu.be/1PlnrJ7t6AA
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, will join @brightfocus.bsky.social for a discussion titled “Can Retinal Implants Restore Vision?”
Learn more about the conversation and how to join below.
Learn more about the conversation and how to join below.
January 27, 2026 at 9:38 PM
Frank Brodie, MD, Science’s Medical Director for Vision and PRIMA, will join @brightfocus.bsky.social for a discussion titled “Can Retinal Implants Restore Vision?”
Learn more about the conversation and how to join below.
Learn more about the conversation and how to join below.
Our PRIMA retinal implant is about the size of a pinhead and thinner than a human hair.
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
January 16, 2026 at 9:56 PM
Our PRIMA retinal implant is about the size of a pinhead and thinner than a human hair.
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
The chip “represents the first treatment to restore vision in persons with advanced geographic atrophy” in clinical trials, according to a new editorial in @nejm.org
Our PRIMA retinal implant is designed to replace the function of light-sensitive cells in the eye that have been lost due to advanced degenerative retinal diseases, restoring functional central vision in clinical trials
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
January 8, 2026 at 11:46 PM
Our PRIMA retinal implant is designed to replace the function of light-sensitive cells in the eye that have been lost due to advanced degenerative retinal diseases, restoring functional central vision in clinical trials
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
Here's what the world looks like to a PRIMA patient science.xyz/technologies...
In clinical trials, our PRIMA retinal implant restored functional vision to patients suffering from geographic atrophy due to age-related macular degeneration.
Take a look inside the labs.
Take a look inside the labs.
December 23, 2025 at 9:36 PM
In clinical trials, our PRIMA retinal implant restored functional vision to patients suffering from geographic atrophy due to age-related macular degeneration.
Take a look inside the labs.
Take a look inside the labs.
In our clinical trial, participants with geographic atrophy experienced something previously thought impossible: meaningful restoration of central vision.
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
December 5, 2025 at 12:42 AM
In our clinical trial, participants with geographic atrophy experienced something previously thought impossible: meaningful restoration of central vision.
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
Learn more about our PRIMA retinal implant here: science.xyz/technologies...
What could you do with world-class neurotech that fits in the palm of your hand?
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
November 25, 2025 at 8:12 PM
What could you do with world-class neurotech that fits in the palm of your hand?
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
The Science Ecosystem has the hardware and software needed to develop next-generation neural engineering therapies.
Learn more here: science.xyz/company/cont...
We are neuroscientists, biologists, cell engineers, electrical engineers, mechanical engineers, software engineers, IC designers, MEMS engineers, clinicians, operators, and more.
We are Science.
Learn more about our work here: science.xyz
We are Science.
Learn more about our work here: science.xyz
November 24, 2025 at 9:22 PM
We are neuroscientists, biologists, cell engineers, electrical engineers, mechanical engineers, software engineers, IC designers, MEMS engineers, clinicians, operators, and more.
We are Science.
Learn more about our work here: science.xyz
We are Science.
Learn more about our work here: science.xyz
Thank you to the many scientists, physicians, and researchers who visited us at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 and shared their excitement for our work building a brighter tomorrow enabled by neural engineering.
If you missed us at #SfN25, learn more here: science.xyz
If you missed us at #SfN25, learn more here: science.xyz
November 21, 2025 at 12:24 AM
Thank you to the many scientists, physicians, and researchers who visited us at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 and shared their excitement for our work building a brighter tomorrow enabled by neural engineering.
If you missed us at #SfN25, learn more here: science.xyz
If you missed us at #SfN25, learn more here: science.xyz
We develop a full range of technologies required for modern neural engineering, building devices aimed at restoring vision, communication and cognition to improve the human condition.
Visit us at Booth #3101 at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 to learn more. #SfN25
Visit us at Booth #3101 at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 to learn more. #SfN25
November 19, 2025 at 5:05 PM
A first glimpse from #SfN2025: our next-gen PRIMA glasses.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
November 18, 2025 at 8:21 PM
A first glimpse from #SfN2025: our next-gen PRIMA glasses.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
The glasses feature an embedded camera and infrared projector that send light signals to our PRIMA retinal implant, providing both power and data.
Experience the PRIMA glasses and preview the next-generation design at Booth #3101.
We’re at the Society for Neuroscience’s (@sfn.org) Annual Meeting 2025 to share our work advancing brain-computer interfaces, from our PRIMA retinal implant to our Science Ecosystem full stack technology platform for neural engineering.
Visit us at Booth #3101 to learn more. #SfN25
Visit us at Booth #3101 to learn more. #SfN25
November 15, 2025 at 10:01 PM
Science founder and CEO @maxhodak.bsky.social joined Jordi Hays and John Coogan on TBPN to talk about our work on brain-computer interfaces, the success of our PRIMA retinal implant, and how the next decade may look very different from the last.
November 15, 2025 at 8:00 PM
Science founder and CEO @maxhodak.bsky.social joined Jordi Hays and John Coogan on TBPN to talk about our work on brain-computer interfaces, the success of our PRIMA retinal implant, and how the next decade may look very different from the last.
Science founder and CEO @maxhodak.bsky.social spoke with @kantrowitz.bsky.social at #WebSummit about breakthroughs in brain-computer interfaces – including Science’s PRIMA implant, which was shown in clinical trials to restore vision in patients with age-related macular degeneration
November 11, 2025 at 10:21 PM
Science founder and CEO @maxhodak.bsky.social spoke with @kantrowitz.bsky.social at #WebSummit about breakthroughs in brain-computer interfaces – including Science’s PRIMA implant, which was shown in clinical trials to restore vision in patients with age-related macular degeneration
On the cover of TIME, 87-year-old Alice Charton, who regained her vision with the PRIMA chip implanted by her doctor, Prof. Eric Souied at CréteilOphtalmo.
November 8, 2025 at 4:28 PM
On the cover of TIME, 87-year-old Alice Charton, who regained her vision with the PRIMA chip implanted by her doctor, Prof. Eric Souied at CréteilOphtalmo.
"This brought me hope,” a PRIMA patient said. “It literally changed my life.”
Read more in @time.com time.com/7330887/brai...
Read more in @time.com time.com/7330887/brai...
November 7, 2025 at 1:29 PM
"This brought me hope,” a PRIMA patient said. “It literally changed my life.”
Read more in @time.com time.com/7330887/brai...
Read more in @time.com time.com/7330887/brai...
@moorfields.bsky.social shared the story of the clinical trial of our PRIMA retinal implant, which demonstrated that the device has restored the ability to read to over 80% of participants.
Read how Moorfields surgeon Mahi Muqit implanted it, how it works, and what a dramatic difference it’s made.
Read how Moorfields surgeon Mahi Muqit implanted it, how it works, and what a dramatic difference it’s made.
November 3, 2025 at 9:58 PM
@moorfields.bsky.social shared the story of the clinical trial of our PRIMA retinal implant, which demonstrated that the device has restored the ability to read to over 80% of participants.
Read how Moorfields surgeon Mahi Muqit implanted it, how it works, and what a dramatic difference it’s made.
Read how Moorfields surgeon Mahi Muqit implanted it, how it works, and what a dramatic difference it’s made.
For more than two decades, a team of scientists, surgeons, and engineers pursued what seemed impossible: restoring functional central vision to people blinded by geographic atrophy.
October 31, 2025 at 12:06 AM
For more than two decades, a team of scientists, surgeons, and engineers pursued what seemed impossible: restoring functional central vision to people blinded by geographic atrophy.
Here’s a brief look at how our PRIMA retinal implant works.
October 28, 2025 at 4:39 PM
Here’s a brief look at how our PRIMA retinal implant works.
“All previous attempts to provide vision with prosthetic devices resulted in basically light sensitivity, not really form vision … We are the first to provide form vision.”
- Dr. Daniel Palanker, co-senior author of the @nejm.org paper on the clinical trial of our PRIMA retinal implant
- Dr. Daniel Palanker, co-senior author of the @nejm.org paper on the clinical trial of our PRIMA retinal implant
October 24, 2025 at 10:24 PM
“All previous attempts to provide vision with prosthetic devices resulted in basically light sensitivity, not really form vision … We are the first to provide form vision.”
- Dr. Daniel Palanker, co-senior author of the @nejm.org paper on the clinical trial of our PRIMA retinal implant
- Dr. Daniel Palanker, co-senior author of the @nejm.org paper on the clinical trial of our PRIMA retinal implant
“People with blindness can read again after retinal implant.” - @nature.com
Nature reported on the results of a landmark clinical trial of our PRIMA retinal implant published in @nejm.org this week.
www.nature.com/articles/d41...
Nature reported on the results of a landmark clinical trial of our PRIMA retinal implant published in @nejm.org this week.
www.nature.com/articles/d41...
October 22, 2025 at 8:05 PM
“People with blindness can read again after retinal implant.” - @nature.com
Nature reported on the results of a landmark clinical trial of our PRIMA retinal implant published in @nejm.org this week.
www.nature.com/articles/d41...
Nature reported on the results of a landmark clinical trial of our PRIMA retinal implant published in @nejm.org this week.
www.nature.com/articles/d41...